In the UK there are approximately 7100 new cases of ovarian cancer per year and 4300 deaths from the disease each year.[3] Ovarian cancer is a rare cancer in the US; however, it accounts for 5% of cancer deaths among women in the US, and is the most lethal of gynaecological cancers.[4] Worldwide, the estimated incidence was 238,700 in 2012, with 151,900 deaths.[5] The median age of patients with ovarian cancer is 60 years, with an estimated lifetime risk of 1 in 70.[6] Although the overall 5-year survival rate is relatively low (46%), it varies by age: women younger than 45 years of age are far more likely to survive (77%) than women aged 75 years and older (20%).[4]

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer